Both the FDA and Novo Nordisk are advising patients and providers to check their supplies of Ozempic for counterfeit product. Individuals in possession of a counterfeit product are urged to call Novo ...

The large-scale study focused on use of semaglutide and non-GLP-1 RAs. An increased risk for nonarteritic anterior ischemic optic neuropathy with semaglutide was seen at 2, 3 and 4 years from the ...

However, at the two-year, three-year, and four-year time points from the index date, those taking semaglutide had an increased risk for NAION (hazard ratios, 2.39, 2.44, and 2.05, respectively).

I am a senior citizen and a beneficiary of the monthly allowance program implemented by our Local Government Unit (LGU). However, I have observed that in our city, senior citizens such as myself are ...

Using real-world data from over 300,000 cases, scientists uncovered a significant link between semaglutide and reported vision problems—raising new concerns about the safety profile of this ...

The researchers found that based on 551 cases, there were an estimated 24,499 emergency department visits attributed to semaglutide adverse events in 2022 through 2023 (mean patient age, 50.9 ...

CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE ...

Semaglutide, the medication better known as Ozempic, reduces the symptoms of a condition that can lead to lower limb amputations in people with diabetes, according to a new study that reinforces ...

Most common gastrointestinal issues seen were nausea/vomiting, abdominal pain, and diarrhea. HealthDay News — The rate of emergency department visits for adverse events among patients dispensed ...

WASHINGTON – The Department of the Army announced today the summer deployments of the following units: The 1st Armored Brigade Combat Team, 1st Infantry Division, to Europe to replace the 3rd ...

I think STRIDE helps us here because among the various drugs for diabetes, if your patient has PAD, you might prioritize a GLP-1 receptor agonist, or specifically semaglutide, based on the results ...

The first started in one apartment but quickly spread to five other units. Photos from a resident show damage to a master bedroom, and you can see through the wall into the other apartment.